Drug Shortage Report for MYLAN-RISPERIDONE
Report ID | 5338 |
Drug Identification Number | 02282275 |
Brand name | MYLAN-RISPERIDONE |
Common or Proper name | RISPERIDONE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RISPERIDONE |
Strength(s) | 2.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | N05AX |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-06-11 |
Actual start date | 2017-07-06 |
Estimated end date | |
Actual end date | 2017-10-02 |
Shortage status | Resolved |
Updated date | 2017-10-04 |
Company comments | Discontinuation reported under ID 16163. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-04-04 | French | Compare |
v1 | 2017-04-04 | English | Compare |